33 related articles for article (PubMed ID: 15188738)
1. Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Bomken S; Enshaei A; Schwalbe EC; Mikulasova A; Dai Y; Zaka M; Fung KTM; Bashton M; Lim H; Jones L; Karataraki N; Winterman E; Ashby C; Attarbaschi A; Bertrand Y; Bradtke J; Buldini B; Burke GAA; Cazzaniga G; Gohring G; De Groot-Kruseman HA; Haferlach C; Nigro LL; Parihar M; Plesa A; Seaford E; Sonneveld E; Strehl S; Van der Velden VHJ; Rand V; Hunger SP; Harrison CJ; Bacon CM; Van Delft FW; Loh ML; Moppett J; Vormoor J; Walker BA; Moorman AV; Russell LJ
Haematologica; 2023 Mar; 108(3):717-731. PubMed ID: 35484682
[TBL] [Abstract][Full Text] [Related]
2. Refractory Burkitt Lymphoma Following Acute Lymphoblastic Leukemia in a Patient with Homozygous
Genç DB; Yıldırmak ZY; Elli M; Ayaz A; Ton Ö
Turk J Haematol; 2024 May; 41(2):126-127. PubMed ID: 38426299
[No Abstract] [Full Text] [Related]
3. CD371 cell surface expression: a unique feature of
Schinnerl D; Mejstrikova E; Schumich A; Zaliova M; Fortschegger K; Nebral K; Attarbaschi A; Fiser K; Kauer MO; Popitsch N; Haslinger S; Inthal A; Buldini B; Basso G; Bourquin JP; Gaipa G; Brüggemann M; Feuerstein T; Maurer-Granofszky M; Panzer-Grümayer R; Trka J; Mann G; Haas OA; Hrusak O; Dworzak MN; Strehl S
Haematologica; 2019 Aug; 104(8):e352-e355. PubMed ID: 30705095
[No Abstract] [Full Text] [Related]
4. Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia.
Fries C; Lee LW; Devidas M; Dai Y; Rabin KR; Gupta S; Loh ML; Kirsch IR; Wood B; Rau RE
Haematologica; 2023 Mar; 108(3):900-904. PubMed ID: 36325891
[No Abstract] [Full Text] [Related]
5. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
[No Abstract] [Full Text] [Related]
6. Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemia.
Fey MF; Tobler A; Stadelmann B; Hirt A; Theilkäs L; Khandjian EW; Ridolfi-Lüthy A; Delaleu B; Weil R; Wagner HP
Eur J Haematol; 1990 Oct; 45(4):215-22. PubMed ID: 1977612
[TBL] [Abstract][Full Text] [Related]
7. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation.
Kreyenberg H; Eckert C; Yarkin Y; Reising M; Willasch A; Handgretinger R; Kremens B; von Stackelberg A; Henze G; Klingebiel T; Bader P
Leukemia; 2009 Jul; 23(7):1355-8. PubMed ID: 19357703
[No Abstract] [Full Text] [Related]
9. Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry.
Kallakury BV; Hartmann DP; Cossman J; Gootenberg JE; Bagg A
Am J Clin Pathol; 1999 Jun; 111(6):759-66. PubMed ID: 10361511
[TBL] [Abstract][Full Text] [Related]
10. [Detection of rearranged immunoglobulin and T-cell receptor genes as a method for characterization of tumor cell clonality in acute lymphoblast leukemia in children].
Meleshko AN; Potapnev MP
Klin Lab Diagn; 2004 Apr; (4):19-22. PubMed ID: 15188738
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis in pediatric acute leukemias.
Bartolo C; Viswanatha DS
Clin Lab Med; 2000 Mar; 20(1):139-82, x. PubMed ID: 10702901
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in ALL.
Deane M; Hoffbrand AV
Cancer Treat Res; 1993; 64():135-70. PubMed ID: 8095791
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
